San Diego, CA, United States of America

Hans H Schiffer

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hans H Schiffer in Mood Disorder Research.

Introduction

Hans H Schiffer is a notable inventor based in San Diego, California. He has made significant contributions to the field of mood disorder research through his innovative patent. His work focuses on understanding the genetic predispositions to recurrent unipolar and bipolar II depressive disorders.

Latest Patents

Hans H Schiffer holds a patent titled "Kainate receptor subunit GLUR7 polymorphisms for determining predispositions to recurrent unipolar and bipolar II depressive disorders." This patent provides methods for determining the predisposition of a subject to a mood disorder by analyzing a biological sample for the presence of specific kainate receptor subunit GluR7 allelic genotypes. The patent highlights the importance of homozygosity for certain nucleotides at position 928 and the expression levels of GluR7 alleles in predicting mood disorders. Additionally, it includes methods for treating or preventing mood disorders and identifying compounds useful for treatment. Transgenic non-human animals expressing specific human GluR7 alleles are also provided as models for studying human mood disorders.

Career Highlights

Hans H Schiffer is affiliated with the Salk Institute, a renowned research institution known for its contributions to biological research. His work at the institute has allowed him to explore the genetic factors influencing mood disorders, leading to his innovative patent.

Collaborations

One of his notable collaborators is Stephen Fox Heinemann, with whom he has worked on advancing research in the field of mood disorders.

Conclusion

Hans H Schiffer's innovative research and patent contributions have significantly advanced the understanding of mood disorders and their genetic predispositions. His work continues to pave the way for new treatment methods and models for studying these complex conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…